Carla Perego

Differential localisation of nPKC delta during cell cycle progression.

Invasive behaviour of glioblastoma cell lines is associated with altered organisation of the cadherin-catenin adhesion system.

Differential interaction of Enigma protein with the two RET isoforms.

PP1 inhibitor induces degradation of RETMEN2A and RETMEN2B oncoproteins through proteosomal targeting.

Glutamate 59 is critical for transport function of the amino acid cotransporter KAAT1.

Chronic hyperglycemia impairs insulin secretion by affecting insulin receptor expression, splicing, and signaling in RIN beta cell line and human islets of Langerhans.

RETMEN2A and RETMEN2B oncoproteins are targets of PP1 inhibitor.

Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).

LIN7 mediates the recruitment of IRSp53 to tight junctions.

Disproportionate hyperproinsulinemia, beta-cell restricted prohormone convertase 2 deficiency, and cell cycle inhibitors expression by human islets transplanted into athymic nude mice: insights into nonimmune-mediated mechanisms of delayed islet graft failure.

AQP1 is not only a water channel: it contributes to cell migration through Lin7/beta-catenin.

Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons.

Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats.

The surface density of the glutamate transporter EAAC1 is controlled by interactions with PDZK1 and AP2 adaptor complexes.

The glial glutamate transporter 1 (GLT1) is expressed by pancreatic beta-cells and prevents glutamate-induced beta-cell death.

Long-lasting remission of type 1 diabetes following treatment with topiramate for generalized seizures.

Neurosteroid allopregnanolone regulates EAAC1-mediated glutamate uptake and triggers actin changes in Schwann cells.

The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach.

Altered insulin receptor signalling and β-cell cycle dynamics in type 2 diabetes mellitus.

The potential role of glutamate in the current diabetes epidemic.

The ontogeny of the endocrine pancreas in the fetal/newborn baboon.

Chronic continuous exenatide infusion does not cause pancreatic inflammation and ductal hyperplasia in non-human primates.